Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Study Comparing Adjuvant Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG Immunotherapy (BCG) Adjuvant Treatment in Patients With Superficial Transitional Cell Carcinoma of the Bladder (STCCB)
Conditions
Interventions
Synergo + MMC
Bacillus Calmette-Guérin
Locations
8
Austria
University Hospital - AKH Vienna
Vienna, Austria
Bnai Zion Medical Center
Haifa, Israel
Wolfson Hospital
Holon, Israel
Hadassah University Hospital
Jerusalem, Israel
Galliera Hospital
Genova, Italy
Istituto Europeo del Oncologia
Milan, Italy
Start Date
February 1, 2002
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2013
Last Updated
October 7, 2014
NCT07222488
NCT05614739
NCT06237920
NCT06441110
NCT06403202
NCT05072600
Lead Sponsor
Medical Enterprises Europe B.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions